Infective endocarditis owing to Mycobacterium abscessus infection is rarely reported. Most cases of infective endocarditis caused by Mycobacterium abscessus are seen in patients after valve replacement. Although early surgical intervention is recommended and medical treatment with antibiotics according to the susceptibility to the pathogen, such as amikacin, imipenem, cefoxitin, quinolones and macrolides, are applied, the course of such endocarditis is usually subacute and often has fatal outcomes. The present case was a 29-year-old male patient who was an intravenous drug user who had recurrent endocarditis caused by Mycobacterium abscessus. Unusually, our reported case was infected on his native valve. However, we experienced recurrence despite antimicrobial therapy. For culture-negative endocarditis, physicians should consider the possibility of Mycobacterium abscessus infection and related treatment difficulties.
Infective endocarditis (IE) is the proliferation of microorganisms on the endocardium of the heart. Endocarditis caused by Mycobacterium abscessus (M. abscessus) is rare and only five cases have been published since 1975. Four of the five patients with M. abscessus endocarditis were associated with prosthetic valve infection. Only one patient with native valve endocarditis caused by M. abscessus has been published [1] . M. abscessus endocarditis has been found to be associated with history of surgery (cardiac, valvular), foreign bodies, trauma, intravenous (IV) injections, hemodialysis or immunocompromised status. Here, we present a case of native valve endocarditis with M. abscessus infection.
CASE PRESENTATION
A 29-year-old male patient who was an IV heroin abuser had an episode of methicillin susceptible Staphylococcus aureus (MSSA)-associated tricuspid valve infective endocarditis that was previously treated once in January 2006. Mild tricuspid regurgitation (TR) and vegetation (0.6 × 0.9 cm) were involved in the septal leaflet of the tricuspid valve as determined by echocardiography. In June 2006, he was readmitted with a fever extending for 1 month. Vegetation (0.75 × 1.66 cm) with high echogenicity involving the septal leaflet of the tricuspid valve and moderate TR was found by echocardiography. A smear from culture medium of blood culture (BACTEC system, SA bottle) showed acid-fast stain (AFS)-positive bacilli. He was treated for miliary tuberculosis (TB) initially with rifampin 600 mg/day and isoniazid 300 mg/day, ethambutol 800 mg/day, pyrazinamide 1,500 mg/day plus streptomycin 1 g/day, and he was discharged in July 2006 with afebrile status. He continued with oral rifampin 600 mg/day and isoniazid 300 mg/day, ethambutol 800 mg/day and pyrazinamide 1,500 mg/ day after discharge.
In August 2006, he was admitted again with relapse of the fever. The blood culture obtained at the patient's hospitalization in June 2006 was identified to be M. abscessus according to a polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP) analysis of the 65-kDa heat shock protein ( Figure 1) (Figures 2A and 2B ). Chest X-ray revealed pneumonia over the right middle lung field. Initial laboratory data revealed: white blood cell count (WBC) 7,730/μL; hemoglobin 10.1 g/dL; platelets 120,000/μL; blood urea nitrogen 35.6 mg/dL; creatinine 2.04 mg/d; and C-reactive protein (CRP) 104 mg/L.
Blood culture still showed AFS-positive bacilli but negative findings for common aerobic pathogens. Because of suspected TB-associated IE, he was treated with rifampin 600 mg/day and isoniazid 300 mg/day, ethambutol 800 mg/day plus clarithromycin 500 mg twice daily. Surgical intervention was strongly suggested, but the patient hesitated and finally received continued medical therapy. Chest computed tomography There were no signs of heart failure. The pneumonialike lesions improved after antibiotic treatment, and laboratory data before discharge were: CRP 73 mg/L (normal range, < 5 mg/L); and WBC 6,670/μL. He was discharged with continuing oral clarithromycin 500 mg twice daily plus ciprofloxacin 400 mg twice daily for 8 weeks at our clinic, and was then lost to follow-up. At his last visit to our clinic in January 2007, we repeated the echocardiography. It revealed that the size of the vegetations had decreased to 0.8 × 1.5 cm and 2.2 × 1.1 cm over the septal and anterior leaflets of the tricuspid valve, respectively, and the TR was still severe. The patient had poor medication compliance and "doctor shopping" between hospitals. Even though we planned for him to receive surgical intervention and a full course of antibiotic treatment, he hesitated and was subsequently lost to follow-up and did not receive further management from us. The patient had positive rheumatoid factor, decreased complement level (C3, 28.1 mg/dL; C4, 9.25 mg/dL) and decreased CD4 count (155/mm 3 ), but was negative for human immunodeficiency virus antibody and negative for antinuclear antibodies.
DISCUSSION
Infective endocarditis caused by M. abscessus is very rare and unique; accordingly, we have reviewed the literature about the care and prognosis of this disease. M. abscessus is grouped with a number of rapidgrowth nontuberculous mycobacteria (NTM), which includes M. fortuitum, M. chelonae, and M. abscessus. These rapid-growth NTM have been found in potable and natural water, and in soil. They can also be isolated from contaminated tap water. Infection with M. abscessus may lead to localized infections such as subcutaneous abscesses, lymphadenitis, pneumonia, keratitis, prosthetic valve endocarditis, osteomyelitis, meningitis and disseminated infection [3] [4] [5] . The pulmonary lesion and the endocarditis caused by M. abscessus in this case were identified based on the PCR-RFLP study of the gene encoding for the 65-kDa heat shock protein [2] . To our knowledge, only one other case has been reported in the literature to have native valve endocarditis caused by M. abscessus [1] . In a review of the English-language publications, endocarditis caused by M. chelonae (formerly M. chelonae subspecies chelonae) or M. abscessus (formerly M. chelonae subspecies abscessus) has been documented in only nine cases. Since M. abscessus has also been classified as M. chelonae before, we reviewed endocarditis with the search terms of M. chelonae and M. abscessus but not of M. fortuitum. Five of the nine cases were infected with M. abscessus and the others were infected by M. chelonae. Seven of them were associated with prosthetic valve endocarditis, but none of them survived after treatment. The only surviving case was associated with native valve endocarditis [1, 3, [5] [6] [7] [8] [9] [10] . Most of the cases infected with NTM endocarditis were subacute and had fatal outcomes, especially those with prosthetic valve endocarditis (Table) . Infective endocarditis owing to NTM infection was considered when associated with the status after valvular and cardiac surgery, immunocompromised hosts, intravenous drug abuse, dialysis, patients who received renal transplant and immunosuppressive therapy, and individuals on corticosteroid therapy [3, 5, 6, 9] .
The case we reported is only the second patient to have native valve endocarditis infected by M. abscessus. The portal of entry in our case was not clear, but may be attributed to his use of tap water for heroin powder dilution and for injection. Another contributing factor was his immune system compromise with low complement, low CD4 level and positive rheumatoid factor, which may be related to his drug abuse, although the decreased complement level and positive rheumatoid factor may be the result of IE.
Rapid-growth NTM has been reported to be resistant to many antimicrobial agents, including most primary and secondary line antituberculosis agents in vitro. However, some strains of M. abscessus and M. chelonae were found to be sensitive to amikacin, clarithromycin, cefoxitin, erythromycin and quinolone [3, 10] . Combination therapy with different classes of antimicrobial agents is usually recommended because 
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Table.
Clinical characteristics of patients with infective endocarditis due to Mycobacterium abscessus monotherapy was found to cause resistance of NTM [11] . The duration of antimicrobial therapy in patients with NTM-related endocarditis is still controversial. Previous reports have suggested that the antimicrobial treatment should last for at least 6 months or 3 months after aggressive surgical intervention [3] . Owing to frequent failure of medical treatment, early surgical intervention in combination with antimicrobial treatment has been recommended for patients with NTM-related endocarditis [3, 4, 9, 10] . Our case was treated with clarithromycin plus amikacin, and antimicrobial therapy was shifted to the oral form of ciprofloxacin plus clarithromycin for 8 weeks after discharge. It is not clear whether the exacerbation of IE could be restrained by clarithromycin plus ciprofloxacin treatment because the patient in our case study was treated for only 8 weeks and then lost to follow-up.
In summary, infective endocarditis caused by M. abscessus and other rapid-growth mycobacterium is not readily diagnosed and treated. For culturenegative endocarditis, awareness of the possibility of NTM infection should be considered, especially when patients have related predisposing factors.
